KS Biomedix Holdings PLC

Acquisitions Xenova sells assets to Bioventix Bioventix Ltd. (Cambridge, UK) Xenova Group PLC (Slough, Berkshire, UK) For £800k ($1.5mm) in cash, oncology and addiction therapeutics company Xenova G

Alizyme's out-licensing pact with Takeda for Japanese rights to the UK biotech's Phase II anti-obesity compound ATL-962 underscores the practical and funding advantages of a Japanese-market deal as a

Using Zebrafish to Find New CNS Drugs Paul Goldsmith, PhD, and his co-founders established DanioLabs Ltd. in October 2001 to develop new drugs for neuro-ophthalmologic disorders. Frustrated at the

Alizyme's £16.1 million, barely discounted placing and open offer illustrates its investors' faith in its low-risk business model and maturing pipeline. It also provides leverage for negotiating the o